Indian pharma sector sees growth at 8 pc CAGR, export rates spike by 9 pc in 2024: Report
The Indian pharma sector has grown at 8 per cent CAGR and has also seen a 9 per cent increase in export rates in 2024, according to a report.
The Indian pharma sector has grown at 8 per cent CAGR and has also seen a 9 per cent increase in export rates in 2024, according to a report.
Domestic manufacturing needed to scale up as the country wanted to dominate the world. Its aim is not to be dependent on anyone.
The risk of further waves of infection remains significant in markets with slow roll-outs of vaccination, including India, but healthcare systems are better prepared after the second wave, which should limit the impact.
North America is the largest exporting region for Indian pharmaceuticals with more than 34 per cent share.
